Mitochondrial damage causes inflammation via cGAS-STING signaling in ketamine-induced cystitis

Jinji Chen1, Shengsheng Liang1, Cheng Li1

  • 1Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.

Abstract

Insights

Mitochondrial damage releases DNA, activating the cGAS-STING pathway and causing ketamine-induced cystitis. Blocking STING reduces inflammation, suggesting it as a therapeutic target for this condition.

Area of Science:

  • Immunology
  • Cell Biology
  • Toxicology

Background:

  • Mitochondrial dysfunction releases mitochondrial DNA (mtDNA), activating the cGAS-STING pathway and promoting inflammation.
  • Factors like oxidative stress, viral infection, and drug toxicity can induce mitochondrial damage.
  • Ketamine-induced cystitis (KC) involves inflammatory pathways, with mtDNA potentially playing a key role.

Purpose of the Study:

  • To investigate the role of mitochondrial DNA (mtDNA) as an inflammatory mediator in ketamine-induced cystitis (KC) via the cGAS-STING pathway.
  • To assess the expression of cGAS and STING in a rat model of KC and in vitro cell models.
  • To explore the therapeutic potential of targeting the cGAS-STING pathway in KC.

Main Methods:

  • Assessed cGAS and STING expression in rat bladder tissue and SV-HUC-1 cells exposed to ketamine.
  • Examined mitochondrial morphology using transmission electron microscopy.
  • Measured reactive oxygen species (ROS) and quantified inflammatory factors/cytokines using qPCR.

Main Results:

  • Ketamine upregulated cGAS and STING expression in vivo and in vitro.
  • STING knockdown inhibited NF-κB p65 and IRF3 nuclear translocation, reducing inflammatory cytokines (IL-6, IL-8, CXCL10).
  • Ketamine-induced mitochondrial damage released mtDNA, which, upon depletion, inhibited the cGAS-STING pathway; mtDNA reintroduction partially restored inflammation.

Conclusions:

  • Confirmed cGAS-STING pathway activation in KC and demonstrated mitochondrial damage.
  • Highlighted the critical role of the cGAS-STING pathway in KC pathogenesis.
  • Suggested the cGAS-STING pathway as a potential therapeutic target for KC.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...